Robinson plc (RBN)
London Exchange · UK · prices in GBX · close of 20 Oct 2026
Key indicators
| Last close | GBX 122.50 |
|---|---|
| 52-week range | 105.05 – 136.76 |
| Return, 1 month / 3 months | −3.9% / −2.0% |
| Return, 1 year / 3 years | −8.4% / +61.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 19.2% |
| Worst drawdown (1 year) | -18.2% |
| Average daily value traded | 1.43M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Robinson plc is a packaging company based in the United Kingdom that makes custom-designed plastic and paperboard packaging for consumer goods brands. It supplies moulded and thermoformed plastic containers, tubes, and cartons, along with related services such as design and tooling. Its customers are mainly manufacturers of food, drink, household and personal care products, who use the packaging for their own branded goods. The company works with clients on packaging that suits their products and their presentation needs.
Robinson plc trades under the code RBN on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Robinson plc (RBN) trades on the London Exchange in UK. It last closed at GBX 122.50 on 20 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,299 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 8.4% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.0% | ||
| From 52-week high | -7.4% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | 6.9% | ||
| 12-month return, skipping the last month | -4.6% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.2% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.43M GBX | ||
| Zero-volume days | 18.3% | ||
| Income | 32 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −3.9% |
| 3 months | −2.0% |
| 6 months | +6.9% |
| 1 year | −8.4% |
| 3 years | +61.3% |
| 5 years | +64.3% |
Signals
| 50-day / 200-day average | 124.63 / 120.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.07 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Sep 2026 | GBP 0.0250 |
| 4 Jun 2026 | GBP 0.0350 |
| 18 Sep 2025 | GBP 0.0250 |
| 5 Jun 2025 | GBP 0.0350 |
| 19 Sep 2024 | GBP 0.0250 |
| 6 Jun 2024 | GBP 0.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.